Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation

Circulation: Cardiovascular Quality and Outcomes

Volumn 4, Issue 3, 2011, Pages 346-354

  Wei, Shaokui ^a   Loyo Berríos, Nilsa I ^a   Haigney, Mark C P ^a   Cheng, Hong ^a   Pinnow, Ellen E ^a   Mitchell, Kristi R ^b   Beachy, James H ^b   Woodward, Albert M ^b   Wang, Yongfei ^c   Curtis, Jeptha P ^c   Marinac Dabic, Danica ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Section of Cardiovascular Medicine   (United States)

Author keywords

Heart failure; Implantable cardioverter defibrillator; Mortality; Natriuretic peptides; Registries

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; ATRIOVENTRICULAR BLOCK; BIVENTRICULAR ASSIST DEVICE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY VENOUS DISSECTION; DEEP VEIN THROMBOSIS; DEFIBRILLATION; DEFIBRILLATOR; DEVICE INFECTION; DISEASE ASSOCIATION; DISEASE REGISTRY; EMBOLISM; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART PERFORATION; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HOSPITAL; HOSPITALIZATION; HUMAN; IMPLANTATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERIPHERAL NERVE INJURY; PHLEBITIS; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; STROKE; SURGICAL RISK; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART ARREST; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 79959694831     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.110.943621     Document Type: Article

References (23)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II InvestigatorsProphylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 2002;346:877-883. (Pubitemid 34984635)
2. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) InvestigatorsProphylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 2004;350:2151-2158. (Pubitemid 38637995)
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) InvestigatorsAmiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 2005;352:225-237. (Pubitemid 40110811)
4. Coats AJ MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials? Int J Cardiol 2002;82:1-5. (Pubitemid 34084909)
5. Zhan C, Baine WB, Sedrakyan A, Steiner C Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis J Gen Intern Med 2008;23(Suppl 1):13-19. (Pubitemid 350295396)
6. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverterdefibrillators J Am Coll Cardiol 2006;47:2493-2497. (Pubitemid 43866387)
7. Daniels LB, Maisel AS Natriuretic peptides J Am Coll Cardiol 2007; 50:2357-2368. (Pubitemid 50011582)
8. Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease N Engl J Med 2005;352:666-675. (Pubitemid 40239214)
9. Yu CM, Sanderson JEPlasma brain natriuretic peptide: an independent predictor of cardiovascular mortality in acute heart failure Eur J Heart Fail 1999;1:59-65. (Pubitemid 30074676)
10. Tapanainen JM, Lindgren KS, Mäkikallio TH, Vuolteenaho O, Leppäluoto J, Huikuri HV Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the betablocking era J Am Coll Cardiol 2004;43:757-763. (Pubitemid 38296472)
11. Verma A, Kilicaslan F, Martin DO, Minor S, Starling R, Marrouche NF, Almahammed S, Wazni OM, Duggal S, Zuzek R, Yamaji H, Cummings J, Chung MK, Tchou PJ, Natale A Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies Heart 2006;92:190-195. (Pubitemid 43131958)
12. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 2002;105:2392-2397. (Pubitemid 34556391)
13. Hammill S, Phurrough S, Brindis R The National ICD Registry: now and into the future Heart Rhythm 2006;3:470-473.
14. Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, McKay C, Wang Y, Lang CM, Pontzer K, Rumsfeld J, Phurrough SE, Curtis JP, Brindis RG Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance Heart Rhythm 2009;6:1397-1401.
15. Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich P, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Lang CM, Harder JC, Brindis RG Review of the registry's first year, data collected, and future plans Heart Rhythm 2007;4:1260-1263. (Pubitemid 47324135)
16. http://www.lexjansen.com/wuss/2006/Analytics/ANL-Dai.pdf (Hierarchical Logistic Regression Modeling with SAS GLIMMIX by Jian Dai, Zhongmin Li, David Rocke; University of California, Davis, CA).
17. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA; National Cardiovascular Data RegistryGender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy Circulation 2009;119: 1078-1084.
18. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC JrPlasma brain natriuretic peptide concentration: impact of age and gender J Am Coll Cardiol 2002;40:976-982. (Pubitemid 34994995)
19. McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel ASB-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study Am J Kidney Dis 2003;41:571-579. (Pubitemid 36278374)
20. Hreybe H, Razak E, Saba S Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients Pacing Clin Electrophysio l2007;30:1091-1095. (Pubitemid 47300648)
21. Birnie D, Tung S, Simpson DBirnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, Krahn A, Parkash R, Khaykin Y, Philippon F, Guerra P, Kimber S, Cameron D, Healey JS Complications associated with defibrillation threshold testing: the Canadian experience Heart Rhythm 2008;5:387-390.
22. Miller WL, Hartman KA, Grill DE, Burnett JC Jr, Jaffe AS Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure Clin Chem 2009;55:78-84.
23. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP BNPguided vs symptom-guided heart failure therapy: the Trial of Intensified vsStandard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial JAMA 2009;301:383-392.